Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of December 2, 2024 • 10:01 PM ET

Date/Time Source News Release
10/22/2024 07:30 AM EDT Newsfile Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites
10/15/2024 07:30 AM EDT Newsfile Awakn Partners with the University of Nottingham for in Vivo Testing of Aminoindane New Chemical Entity (NCE) Pre-Clinical Program
10/04/2024 07:30 AM EDT Newsfile Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program
09/18/2024 07:30 AM EDT Newsfile Awakn Life Sciences Announces Upsizing and Closing of Tranche of Private Placement Financing
08/28/2024 07:30 AM EDT Newsfile Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program
08/09/2024 07:30 AM EDT Newsfile Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder
07/31/2024 07:30 AM EDT Newsfile Awakn Life Sciences Announces Closing of Tranche of Private Placement and Warrant Extension
07/22/2024 05:00 PM EDT Newsfile Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio
07/18/2024 07:30 AM EDT Newsfile Awakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLC
06/04/2024 07:30 AM EDT Newsfile Awakn Life Sciences Announces Closing of Tranche of Private Placement
Page

Additional News

As of December 2, 2024 • 10:01 PM ET

Date/Time Source News Release
05/07/2024 05:54 AM EDT SeekingAlpha Psychedelic therapy: FDA panel to review first ever MDMA-assisted PTSD treatment
04/03/2024 08:41 AM EDT SeekingAlpha Awakn Life Sciences inks licensing partnership deal with Oklahoma-based clinic
04/28/2023 09:04 AM EDT SeekingAlpha Awakn Life Sciences  reports Q4 results
04/26/2023 09:09 AM EDT SeekingAlpha Awakn Life Sciences launches up to $3M units offering
04/12/2023 10:51 AM EDT SeekingAlpha Awakn Life Sciences stake in Awakn Bristol increases to 100%
02/09/2023 03:54 PM EST Green Market Report OTC Flags Awakn Life Sciences for Stock Promotion
10/10/2022 08:36 AM EDT Green Market Report The Plan For Psychedelics To Cure Alcoholism
09/15/2022 09:20 AM EDT SeekingAlpha Awakn Life Sciences  reports Q2 results
09/15/2022 09:16 AM EDT Green Market Report Awakn Life Sciences Revenues Rise Along With Patients
07/15/2022 09:37 AM EDT SeekingAlpha Awakn Life Sciences CFO resigns; inks contracts with clinics for alcohol use disorder therapy
Page